AbbVie Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by AbbVie Inc. on October 12, 2016. The filing addresses Item 5.02 regarding the departure of a senior officer and the appointment of a successor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to personnel changes and does not contain financial performance data.
Material Changes
The material change reported is the upcoming transition of the Vice President, Controller role:
- Resignation: Thomas A. Hurwich will resign as Vice President, Controller effective February 28, 2017, following a 33-year career. He intends to retire later in 2017.
- Appointment: Robert A. Michael has been appointed Vice President, Controller effective March 1, 2017.
Management Commentary and Background
Robert A. Michael, 46, has been an AbbVie officer since 2015. His prior roles within AbbVie include Vice President, Treasurer (since 2015), Vice President, Controller, Commercial Operations (2013-2015), and Vice President, Financial Planning and Analysis (2012-2013). Previously, he served at Abbott Laboratories (AbbVie's former parent) as Division Controller, Nutrition Supply Chain (2010-2012) and joined Abbott in 1993.
Investor Verification Points
- Confirm the effective dates of the Controller transition (Feb 28, 2017, and March 1, 2017).
- Verify Robert A. Michael's tenure and specific prior roles within AbbVie and Abbott Laboratories.
- Note that this filing contains no financial results or guidance updates.